Marksans Pharma experienced an increase of 1.94%, reaching Rs 186.30, following the announcement that it received zero observations during a current Good Manufacturing Practice (cGMP) inspection conducted by the US Food and Drug Administration
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
The Johnson & Johnson's (J&J) CAPLYTA (lumateperone) product has been given a green light by the U.S. Food and Drug Administration (USFDA) to be used as adjunctive therapy with antidepressants for adult major depressive disorder
.png "Pfizer Beats Novo Nordisk in $10 Billion Metsera Deal")
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
Lupin has unveiled an ambitious tactical plan aimed at accelerating its growth through a strong product pipeline, widened market reach, and improved financial health. The company's latest update emphasizes a tightly managed approach
The Indian Pharmacopoeia Commission (IPC) intends to work on monographs and quality standards of three important TB drugs, such as delamanid, pretomanid and a fixed-dose combination (FDC) of rifapentine and isoniazid...
Positive results from the pivotal LIBERTY-AFRS-AIMS Phase 3 trial reveal that Dupixent considerably enhanced symptoms in adults and children aged six years and older with allergic fungal rhinosinusitis (AFRS). The investigational treatment met...
Biocon Ltd. informed that its Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh
Torrent Pharmaceuticals got the green light from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to produce and sell Prucalopride Oral Solution (0.2 mg/mL).
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")